ANN ARBOR, Michigan — A new analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered. It's a concept that could be applied to all cancer centers nationwide. Immune checkpoint inhibitors were initially tested and approved at weight-based dosages but then moved to one-size-fits-all flat doses, in part to reduce drug waste. But researchers from the University of Michigan Rogel Cancer Center found that if vials intended for a single patient's use are shared across patients, then physicians could deliver customized doses while also reducing waste and costs.

https://www.miragenews.com/new-approach-to-delivering-cancer-drugs-could-1044810/

#miragenews